Cascade Bio has raised $6M to enhance enzyme-based biomanufacturing processes and expand its breakthrough biocatalysts.
PRIVATESep 09, 2025
Amount Raised
$6 Million
Round Type
Seed
DenverBiotechnology
Investors
10 VC1FlourishStray Dog CapitalRange VenturesAmplifyEndurance28
Description
Cascade Bio has secured $6M to accelerate the shift from petrochemicals to biomanufacturing. The funding includes a $2.8M seed round led by Endurance28 and $3.2M in nondilutive funding from NSF. This investment will allow Cascade to expand the delivery of its high-performing enzymes. The company aims to dramatically improve costs and ease-of-use for biocatalysis in industrial applications.
Who to call at Cascade Bio, and when
A new round usually means Cascade Bio is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Cascade Bio raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Cascade Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cascade Bio. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Cascade Bio
Location
Denver, Colorado, United States
About
Cascade Bio is creating more productive enzymes for economical biomanufacturing of sustainable chemicals. Cascade addresses the growing need for stable, long-lasting biocatalysts using our patent-pending enzyme immobilization platform. By combining nature’s catalyst, enzymes, with state-of-the-art materials, we can create something that is greater than the sum of its parts. Join us as we help build the future bioeconomy.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cascade Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
DenverBiotechnology